Featured Research

from universities, journals, and other organizations

Preventing Variceal Bleeding

Date:
September 11, 2007
Source:
John Wiley & Sons, Inc.
Summary:
Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of such bleeding, it can have fatal complications and is more expensive. Patients with liver disease often develop portal hypertension from a blockage in the blood flow through the liver.

Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of such bleeding, it can have fatal complications and is more expensive.

Related Articles


Patients with liver disease often develop portal hypertension from a blockage in the blood flow through the liver. The increased blood pressure in the portal vein causes large veins, called varices, to develop across the esophagus and stomach to bypass the blockage. The se varices become fragile and can bleed easily, causing frightening symptoms like vomiting blood, as well as ascites and encephalopathy. Two ways to prevent variceal bleeding are beta blockers and endoscopic variceal ligation, however it is unclear which is better for patients.

To compare the safety and efficacy of the two therapies in the prevention of primary variceal bleeding, researchers led by Lorenzo Norberto and Lino Polese of the University of Padova in Italy, conducted a randomized controlled trial among patients awaiting liver transplantation. Between September 2001 and December 2005, they enrolled sixty-two patients with Child-B-C cirrhosis and high-risk esophagal varices into their study. The patients were randomly divided between treatment with the beta blocker, propranolol, or variceal banding. All patients had an EGD and a clinical examination every 6 months after beginning treatment.

The 31 patients who took beta blockers started on a low dose and increased it until they achieved a 25 percent reduction of their baseline heart rate. Five patients had to suspend the treatment due to complications including bradycardia, persistent hypotension and vertigo. Of the 26 who continued the treatment, three eventually bled from esophageal varices and two died of such bleeding. During the mean follow-up of 7.6 months, ten of the patients underwent liver transplantation.

Of the 31 patients treated with ligation, two suffered a dramatic hemorrhage a few days after the first treatment and required emergency treatment. One patient recovered, the other died. The remaining patients underwent three ligation sessions to completely eradicate their varices. During the mean follow up of almost 15 months, two patients died of liver failure after 1 and 7 months respectively, while 14 of the patients received a liver transplant.

Both propranolol and endoscopic banding considerably reduced the expected incidence of bleeding, normally 30 percent after one year. The beta blocker lowered the risk to less than 10 percent, the banding to less than 7 percent. Although some patients in each group experienced adverse events related to their treatment, only banding was associated with a death.

"Beta blockers should remain the first choice of prophylactic therapy in candidates for liver transplantation," the authors report, though banding should be used when beta-blockers are contraindicated. "Both propranolol and endoscopic banding are similarly effective in reducing the incidence of variceal bleeding in cirrhotic patients with high risk varices, but ligation can be complicated by severe and fatal bleeding and is significantly more expensive," they conclude. The mean cost for treatment with propranolol was $1425, compared to $4289 for banding.

In an accompanying editorial, Thomas Boyer of the Liver Research Institute at Arizona Health Sciences Center applauds the strides that have been made however, he says, "there are still areas where further studies are warranted in the prevention and management of variceal bleeding." Not all patients treated with beta-blockers benefit from the treatment and remain at high risk for bleeding.

"Identification of new drugs that lower portal pressure to the same or greater degree than beta-blockers with fewer side-effects are being sought and if found will further improve the management of the patient with varices," he says.

These findings are published in the September issue of Liver Transplantation, a journal by John Wiley & Sons.

Article: "A Randomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation." Norberto, Lorenzo; Polese, Lino; Cillo, Umberto; Grigoletto, Francesco; Burroughs, Andrew; Neri, Daniele; Zanus, Giacomo; Boccagni, Patrizia; Burra, Patrizia; D'Amico, Davide. Liver Transplantation; September 2007; (DOI: 10.1002/lt.21083).

Editorial: "Clinical Trials for Variceal Bleeding: And the Winner is--The Patient." Boyer, Thomas. Liver Transplantation; September 2007; (DOI: 10.1002/lt.21122).


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Preventing Variceal Bleeding." ScienceDaily. ScienceDaily, 11 September 2007. <www.sciencedaily.com/releases/2007/09/070906105131.htm>.
John Wiley & Sons, Inc.. (2007, September 11). Preventing Variceal Bleeding. ScienceDaily. Retrieved April 24, 2015 from www.sciencedaily.com/releases/2007/09/070906105131.htm
John Wiley & Sons, Inc.. "Preventing Variceal Bleeding." ScienceDaily. www.sciencedaily.com/releases/2007/09/070906105131.htm (accessed April 24, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, April 24, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

85 Killed in Niger by Meningitis Since Start of Year

85 Killed in Niger by Meningitis Since Start of Year

AFP (Apr. 24, 2015) A meningitis outbreak in Niger has killed 85 people since the start of the year prompting authorities to close schools in the capital Niamey until Monday. Video provided by AFP
Powered by NewsLook.com
C-Section Births a Trend in Brazil

C-Section Births a Trend in Brazil

AFP (Apr. 24, 2015) More than half of Brazil&apos;s babies are born via cesarean section, as mothers and doctors opt for a faster and less painful experience despite the health risks. Duration: 02:02 Video provided by AFP
Powered by NewsLook.com
Anti-Malaria Jab Hope

Anti-Malaria Jab Hope

Reuters - News Video Online (Apr. 24, 2015) The world&apos;s first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
3D Food Printing: The Meal of the Future?

3D Food Printing: The Meal of the Future?

AP (Apr. 23, 2015) Developers of 3D food printing hope the culinary technology will revolutionize the way we cook and eat. (April 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins